|
LUMO
|
Lumos Pharma, Inc.
|
US
|
NASDAQ
|
|
LVTX
|
Lava Therapeutics B.V.
|
US
|
NASDAQ
|
|
LYEL
|
Lyell Immunopharma, Inc.
|
US
|
NASDAQ
|
|
MAIA
|
MAIA Biotechnology, Inc.
|
US
|
AMEX
|
|
MASS
|
908 Devices Inc.
|
US
|
NASDAQ
|
|
MDXH
|
MDxHealth SA
|
US
|
NASDAQ
|
|
MEDP
|
Medpace Holdings, Inc.
|
US
|
NASDAQ
|
|
MESO
|
Mesoblast Limited
|
US
|
NASDAQ
|
|
MGNX
|
MacroGenics, Inc.
|
US
|
NASDAQ
|
|
MGTA
|
Magenta Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MITO
|
Stealth BioTherapeutics Corp.
|
US
|
NASDAQ
|
|
MRSN
|
Mersana Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MRVI
|
Maravai LifeSciences Holdings, Inc.
|
US
|
NASDAQ
|
|
MTD
|
Mettler-Toledo International, Inc.
|
US
|
NYSE
|
|
MXCT
|
MaxCyte, Inc.
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
US
|
NASDAQ
|
|
NAUT
|
Nautilus Biotechnology, Inc.
|
US
|
NASDAQ
|
|
NBSE
|
NeuBase Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NBY
|
NovaBay Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
NEPT
|
Neptune Technologies & Bioresources Inc
|
US
|
NASDAQ
|